INSIGHTS ON DRUG DEVELOPMENT
-
![Päivi Tolstoy]( "Ask Us Anything: Päivi Tolstoy On The Future Of API Manufacturing")
Ask Us Anything: Päivi Tolstoy On The Future Of API ManufacturingPäivi Tolstoy, Manager of Process Development at Cambrex Karlskoga, on why sustainability is the trend to watch in API manufacturing — and why the real question is how few steps it takes to build a complex molecule.
-
![Crude or Purified]( "A Fast And Simple ddPCR Assay For In-Depth AAV Characterization")
A Fast And Simple ddPCR Assay For In-Depth AAV CharacterizationAchieve precise AAV characterization with a streamlined digital assay. This video illustrates a rapid, four-step workflow that delivers accurate empty-to-full ratios in under eight hours.
-
![GettyImages-1346675635-laboratory-analysis-research-microscope]( "Characterization And Impurity Profiling Of Combined Amylin And GLP-1 Analogs")
Characterization And Impurity Profiling Of Combined Amylin And GLP-1 AnalogsGLP-1 receptor agonists are transforming diabetes and weight loss treatment. Discover how to enable precise impurity analysis and characterization of complex, fatty acid-modified peptide therapeutics.
-
![GettyImages-2169874381-digital-ai-development-technology]( "An Integrated Analytical Approach To Lipase Risk Management In Biologics Development")
An Integrated Analytical Approach To Lipase Risk Management In Biologics DevelopmentConventional HCP testing cannot confirm whether residual lipases remain enzymatically active. Here, the authors examine why functional activity data are essential for managing polysorbate-related stability risk in biologics development.
-
Fast And Scalable Fc Quantitation In Supernatants3/24/2025
In biopharmaceutical development, the Fc PAIA Titer assay offers a fast, cost-effective, and automatable solution for high-throughput Fc quantification to enhance efficiency, support research, and accelerate production advancements.
-
Deciphering Nanoparticle Properties With AF45/6/2026
Discover how risk‑based, phase‑appropriate synthesis enables safe, efficient production of highly potent compounds while balancing speed, worker safety, and regulatory readiness in early development.
-
Introducing 2 New Highly Effective ADC Payloads For Cancer Therapeutics11/6/2024
Unlock the potential of antibody-drug conjugates (ADCs) by exploring our novel payloads, designed for easy access and evaluation, to accelerate your ADC drug development with proven efficacy and safety.
-
Navigating The Development Of Dry Powder For Inhalation9/9/2026
A CDMO-authored framework for navigating dry powder inhaler development, covering target product profile definition, API characterization, particle engineering technology selection, and encapsulation considerations.
-
Best-In-Class Nanodevelopment Capabilities2/3/2025
A highly specialized team excels in creating unique nanoparticles for both small and large molecule APIs. Leveraging cutting-edge technology, they produce nanoformed materials as small as 10 nanometers.
DRUG DEVELOPMENT SOLUTIONS
-
![iStock-1282804749-computer-quality-check]( "Method Optimization")
We offer a comprehensive method optimization service to take early stage development methods with poor stability indication, excessive run time lengths, or legacy column chemistries and modify them.
-
![leica-microsystems-dm6-b-hero]( "Intelligent Automation for Life Science and Clinical Applications")
Leica DM6 B Upright Microscope
Increase your work efficiency with the Leica DM4 B or Leica DM6 B upright digital research microscopes! Both are ideally suited to making your work life easier in biomedical research and clinical labs alike.
- Simplify your workflow with automated functions and easy-to-use software
- Easily capture publication-quality images by utilizing the 19-mm sCMOS camera imaging port
- Create fast overviews of your samples and identify the important details instantly with the LAS X Navigator Software
- Have great flexibility through the choice of accessories
-
![AccuSEQ]( "From Process Development To QC—Optimize Your mAbs Workflow")
See how integrated analytical capabilities help improve visibility across mAb workflows, enabling faster decisions, stronger process control, and reliable quality outcomes from development through QC.
-
![iStock-1298328343-pill-tablet-bottle-prescription-OSD-oral]( "Controlled Substances")
Cambrex holds US Drug Enforcement Agency (DEA) licenses for process research, development, manufacturing, and importation of Schedule I to IV controlled substances.
-
![GettyImages-2158124620-scientist-laboratory-containers-testing-analysis]( "Testosterone API Catalog")
Review three of our key compounds — Testosterone Base, Testosterone Cypionate, and Testosterone Propionate — each presented with essential identifiers such as CAS numbers, structural features, and typical marketed dosage forms.
